Neal L. Benowitz, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2071.
Requests for Single Reprints: Neal L. Benowitz, MD, Chief, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, Box 1220, San Francisco, CA 94143-1220; e-mail, Neal.Benowitz@ucsf.edu.
Author Contributions: Conception and design: N.L. Benowitz.
Analysis and interpretation of the data: N.L. Benowitz.
Drafting of the article: N.L. Benowitz.
Critical revision of the article for important intellectual content: N.L. Benowitz.
Final approval of the article: N.L. Benowitz.
Provision of study materials or patients: N.L. Benowitz.
Administrative, technical, or logistic support: N.L. Benowitz.
Collection and assembly of data: N.L. Benowitz.
Learn more about subscription options.
Register Now for a free account.
Benowitz NL. Comprehensive Nicotine Regulation to End the Combustible Tobacco Epidemic. Ann Intern Med. [Epub ahead of print 15 August 2017]:. doi: 10.7326/M17-2071
Download citation file:
Published: Ann Intern Med. 2017.
Cardiology, Coronary Risk Factors, Smoking.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only